Literature DB >> 7537042

Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-kappa B/Rel proteins.

C E Goldring1, R Narayanan, P Lagadec, J F Jeannin.   

Abstract

The activity of the inducible nitric oxide synthase enzyme (iNOS) is tightly controlled, partly at the transcriptional level. We find NF-kappa B/Rel activation (p50-p50 and p50-p65) in RAW 264.7 macrophages after lipopolysaccharide treatment and binding to both NF-kappa B sites in the mouse iNOS promoter. To delineate the importance of NF-kappa B/Rel in iNOS gene transcription, we used an unusually direct approach to try to improve on the antioxidant-treatment or reporter techniques, namely the depletion of NF-kappa B/Rel activity through the use of a phosphorothioate-modified oligonucleotide containing three copies of the NF-kappa B consensus sequence. The reduction in NF-kappa B/Rel activity (particularly that binding to the downstream of the two sites) was associated with a 50% reduction in NO output and a reduction in the quantity of the iNOS protein expressed. These results point to the probability that physiologically relevant NF-kappa B/Rel activators or repressors other than lipopolysaccharide might crucially affect the macrophage NO response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537042     DOI: 10.1006/bbrc.1995.1472

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells.

Authors:  R Friedl; T Moeslinger; B Kopp; P G Spieckermann
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 2.  Nitric oxide in invertebrates.

Authors:  M Colasanti; G Venturini
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

3.  Myotrophin/V-1 does not act as an extracellular signal to induce myocyte hypertrophy.

Authors:  Pascal Knuefermann; Shu-Ping Shi; Peter Chen; Yashushi Sakata; Georg Baumgarten; Natarajan Sivasubramanian
Journal:  Tex Heart Inst J       Date:  2006

4.  Evidence for control of nitric oxide synthesis by intracellular transforming growth factor-beta1 in tumor cells. Implications for tumor development.

Authors:  P Lagadec; S Raynal; B Lieubeau; N Onier; L Arnould; V Saint-Giorgio; D A Lawrence; J F Jeannin
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

5.  Enteropathogenic Escherichia coli outer membrane proteins induce iNOS by activation of NF-kappaB and MAP kinases.

Authors:  Vasantha Malladi; Manjula Puthenedam; Peter H Williams; Arun Balakrishnan
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

6.  Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin.

Authors:  Yu-Lin Yang; Lea-Yea Chuang; Jinn-Yuh Guh; Shu-Fen Liu; Min-Yuan Hung; Tung-Nan Liao; Yu-Lun Huang
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

7.  In vivo protein binding and functional analysis of cis-acting elements in the U3 region of the bovine leukemia virus long terminal repeat.

Authors:  J Xiao; G C Buehring
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6.

Authors:  C E Goldring; S Reveneau; M Algarté; J F Jeannin
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

9.  Hypoxia regulates iNOS expression in human normal peritoneal and adhesion fibroblasts through nuclear factor kappa B activation mechanism.

Authors:  Zhong L Jiang; Nicole M Fletcher; Michael P Diamond; Husam M Abu-Soud; Ghassan M Saed
Journal:  Fertil Steril       Date:  2008-02-20       Impact factor: 7.329

10.  Synthesis of 2-arylindole derivatives and evaluation as nitric oxide synthase and NFκB inhibitors.

Authors:  Xufen Yu; Eun-Jung Park; Tamara P Kondratyuk; John M Pezzuto; Dianqing Sun
Journal:  Org Biomol Chem       Date:  2012-11-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.